Skip to Page Content

FREE PREVIEW | Strategic Transactions subscribers get full access to this deal

Executive Summary

LifeCycle Pharma (improves on delivery of immunosupression and cardiovascular drugs) has entered into agreements with Novartis AG's generics unit Sandoz and Merck KGAA's Merck Generics to develop and commercialize fenofibrate in the US and Europe, respectively, to treat high cholesterol.


Purchase this Deal

$75.00   Buy Now


For $75.00, purchase this deal and receive immediate online access. 100% Satisfaction Guarantee.


Strategic Transactions

Subscribers get more deal detail, updates, deal financials, deal products, and company information.

Learn More

Already a Subscriber?

Log in for complete access.

Log In
DEALS ON DEMAND

Tell us what you're looking for and we'll do the work for you. Our Deal Search service provides you the deals you need, when you need them.

For more information Call Toll-Free (800) 332-2181 or +1 (908) 748-1221.
Questions?

Call Toll-Free (800) 332-2181 or +1 (908) 547-2159.